GL1X · GenesisL1 explorer

Research workbench

The crystal structure of upa complex with peptide inhibitor MH027 at PH4.6

Analyse The crystal structure of upa complex with peptide inhibitor MH027 at PH4.6 in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
3OX7
Type
protein
Length
259 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Urokinase-type plasminogen activator; MH027
EC
3.4.21.73
UniProt
P00749
Ligands
SO4
Pockets
1 · best druggability 0.40

Structure

x-ray diffraction · 2 distinct chains · 11% helix, 36% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
UUrokinase-type plasminogen activator (EC 3.4.21.73)protein24511% helix, 38% strandP00749
PMH027protein1421% helix, 0% strand—

Ligands and binding sites

  • SO4 · Sulfate ion · ion · chains U
  • PG4 · Tetraethylene glycol · additive · chains U

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11390.400.7421empty

Interfaces

1 interface between chains.

  • U–P · 714 Ų buried · 20 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 6 disulfide (disulfide).

Compared structures

  • 3OX7 · The crystal structure of uPA complex with peptide inhibitor MH027 at pH4.6 · the same entry in another collection · chain U against U, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.